Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as the inaugural Director of the School’s Kahlert Institute for Addiction Medicine